BR112023011258A2 - Composição para melhoria do cabelo - Google Patents

Composição para melhoria do cabelo

Info

Publication number
BR112023011258A2
BR112023011258A2 BR112023011258A BR112023011258A BR112023011258A2 BR 112023011258 A2 BR112023011258 A2 BR 112023011258A2 BR 112023011258 A BR112023011258 A BR 112023011258A BR 112023011258 A BR112023011258 A BR 112023011258A BR 112023011258 A2 BR112023011258 A2 BR 112023011258A2
Authority
BR
Brazil
Prior art keywords
composition
hair
hair improvement
improvement
improving
Prior art date
Application number
BR112023011258A
Other languages
English (en)
Inventor
Hirotaro Fukuoka
Original Assignee
Dr Cherry Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Cherry Inc filed Critical Dr Cherry Inc
Publication of BR112023011258A2 publication Critical patent/BR112023011258A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/06—Preparations for styling the hair, e.g. by temporary shaping or colouring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/12—Preparations containing hair conditioners
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q9/00—Preparations for removing hair or for aiding hair removal
    • A61Q9/04—Depilatories
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

composição para melhoria do cabelo. a presente invenção fornece um composto para melhorar o volume ou a qualidade do cabelo, e uma composição contendo o composto. especificamente, de acordo com a presente invenção, é fornecida uma composição contendo pioglitazona para uso na melhoria do volume ou da qualidade do cabelo.
BR112023011258A 2020-12-07 2021-12-03 Composição para melhoria do cabelo BR112023011258A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020202460A JP6925072B1 (ja) 2020-12-07 2020-12-07 毛髪改善のための組成物
PCT/JP2021/044394 WO2022124212A1 (ja) 2020-12-07 2021-12-03 毛髪改善のための組成物

Publications (1)

Publication Number Publication Date
BR112023011258A2 true BR112023011258A2 (pt) 2023-10-31

Family

ID=77364576

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112023011258A BR112023011258A2 (pt) 2020-12-07 2021-12-03 Composição para melhoria do cabelo

Country Status (12)

Country Link
US (1) US20230181553A1 (pt)
EP (1) EP4260857A1 (pt)
JP (2) JP6925072B1 (pt)
KR (1) KR20230116050A (pt)
CN (1) CN115361951B (pt)
AU (1) AU2021395980A1 (pt)
BR (1) BR112023011258A2 (pt)
CA (1) CA3204679A1 (pt)
IL (1) IL294882A (pt)
MX (1) MX2023006632A (pt)
TW (1) TW202237104A (pt)
WO (1) WO2022124212A1 (pt)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8796282B2 (en) * 2007-03-28 2014-08-05 Case Western Reserve University Method of treating dermatological disorders
WO2010017895A1 (en) * 2008-08-09 2010-02-18 Merck Patent Gmbh Use of indole compounds as a cosmetic
UA105037C2 (uk) * 2009-02-16 2014-04-10 Джуліані Інтернешнл Лімітед Способи лікування патологічних станів, пов'язаних з волоссям
US11406668B2 (en) 2017-10-02 2022-08-09 Hirotaro FUKUOKA Pharmaceutical composition for use in improving quality of scalp or skin, wound healing, or improving quality of hair
JP6628946B2 (ja) 2017-12-26 2020-01-15 大太朗 福岡 増毛、頭皮若しくは皮膚の改質、創傷治癒、骨形成促進、または毛髪の改質に用いるための医薬組成物
JP6558713B1 (ja) * 2018-09-18 2019-08-14 株式会社コンフェスタ 角質軟化組成物

Also Published As

Publication number Publication date
IL294882A (en) 2022-09-01
JP2022090217A (ja) 2022-06-17
WO2022124212A1 (ja) 2022-06-16
CA3204679A1 (en) 2022-06-16
EP4260857A1 (en) 2023-10-18
KR20230116050A (ko) 2023-08-03
US20230181553A1 (en) 2023-06-15
JPWO2022124212A1 (pt) 2022-06-16
AU2021395980A1 (en) 2023-07-06
JP6925072B1 (ja) 2021-08-25
CN115361951B (zh) 2024-04-19
MX2023006632A (es) 2023-07-20
TW202237104A (zh) 2022-10-01
CN115361951A (zh) 2022-11-18
AU2021395980A9 (en) 2024-04-18

Similar Documents

Publication Publication Date Title
BR112022011421A2 (pt) Inibidores da proteína mutante kras
CL2020002026A1 (es) Inhibidor de fap.
CL2023000555A1 (es) Compuestos y métodos para el tratamiento de infecciones virales
CO2019005287A2 (es) Compuestos de 7-feniletilamino-4h-pirimido[4,5-d][1,3]-oxazin-2-ona como inhibidores de idh1 e idh2 mutantes
UY38326A (es) Constructos de anticuerpos para cldn18.2 y cd3
UY36422A (es) Benzamidas sustituidas con 1,3-tiazol-2-ilo
CL2021002656A1 (es) Compuestos de pirrolotriazina, inhibidores selectivos de proteínas quinasas kit y pdgfralfa; composición y uso.
BR112023014751A2 (pt) Combinação de um inibidor de tead de 3-(imidazol-4-il)-4-(amino)-benzenossulfonamida com um inibidor de egfr e/ou inibidor de mek para uso no tratamento de câncer de pulmão
BR112018012177A2 (pt) ?moduladores de hidantação de canais kv 3?
ECSP21026021A (es) Moduladores de la expresión de pnpla3
BR112016028998A2 (pt) composição polimerizável para material óptico e uso da mesma
CL2009000084A1 (es) Compuestos derivados de sulfonamida sustituida, moduladores de receptores de bradiquinina; composicion farmaceutica que contiene a los compuestos; y uso en el tratamiento del dolor agudo, neuropatico o cronico, entre otros.
CL2020001349A1 (es) Compuestos, composición y uso de los mismos como moduladores de la expresión de pcsk9. (divisional solicitud 201902574)
BR112017022971A2 (pt) aperfeiçoamentos em ou com relação a compostos orgânicos
TWD205285S (zh) 飲料瓶之止擋件
BR112021017670A2 (pt) Compostos de neuregulina-4 e métodos de uso
BR112017010453A2 (pt) composição adesiva com mudança de cor
CO2022000266A2 (es) Inhibidores de enzimas
CL2020003010A1 (es) Moduladores de la expresión de apol1
CO2021007006A2 (es) Moduladores de la expresión de irf5
TWD203194S (zh) 化妝品用容器
BR112021016512A2 (pt) Anticorpo anti pd-l1 e uso do mesmo
CL2018001276A1 (es) Composición antimicrobiana para el revestimiento de superficies
BR112023011258A2 (pt) Composição para melhoria do cabelo
BR112023001471A2 (pt) Composição farmacêutica de anticorpo anti-pd-1 e uso da mesma